Cargando…

Adjunctive Perampanel in Older Patients With Epilepsy: A Multicenter Study of Clinical Practice

BACKGROUND: Clinical data regarding use of newer antiseizure medications (ASMs) in an older population are limited. In randomized-controlled, placebo-controlled trials, older patients are under-represented, and protocols deviate markedly from routine clinical practice, limiting the external validity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lattanzi, Simona, Cagnetti, Claudia, Foschi, Nicoletta, Ciuffini, Roberta, Osanni, Elisa, Chiesa, Valentina, Dainese, Filippo, Dono, Fedele, Canevini, Maria Paola, Evangelista, Giacomo, Paladin, Francesco, Bartolini, Emanuele, Ranzato, Federica, Nilo, Annacarmen, Pauletto, Giada, Marino, Daniela, Rosati, Eleonora, Bonanni, Paolo, Marrelli, Alfonso
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266697/ https://www.ncbi.nlm.nih.gov/pubmed/34075567 http://dx.doi.org/10.1007/s40266-021-00865-3

Ejemplares similares

Perampanel as add-on therapy in epilepsies with known etiology: A single center experience with long-term follow-up
por: Nilo, Annacarmen, et al.
Publicado: (2020)

Adjunctive perampanel for glioma-associated epilepsy()
por: Dunn-Pirio, Anastasie M., et al.
Publicado: (2018)

Seizures, Epilepsy, and NORSE Secondary to Autoimmune Encephalitis: A Practical Guide for Clinicians
por: Vogrig, Alberto, et al.
Publicado: (2022)

Sustained seizure freedom with adjunctive brivaracetam in patients with focal onset seizures
por: Lattanzi, Simona, et al.
Publicado: (2022)

Efficacy of perampanel as an adjunctive therapy in pediatric focal epilepsy
por: Zhang, Wei-Ran, et al.
Publicado: (2023)

Adverse Events During Perampanel Adjunctive Therapy in Intractable Epilepsy
por: Youn, Song Ee, et al.
Publicado: (2018)

Effectiveness of perampanel as the only add‐on: Retrospective, multicenter, observational real‐life study on epilepsy patients
por: Gasparini, Sara, et al.
Publicado: (2022)

Neurological disorders in COVID-19: a case of Acute Disseminated Encephalomyelitis in an adult patient
por: Verriello, Lorenzo, et al.
Publicado: (2022)

Pre- and Post-surgical Poor Seizure Control as Hallmark of Malignant Progression in Patients With Glioma?
por: Pauletto, Giada, et al.
Publicado: (2022)

Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)
por: Lattanzi, Simona, et al.
Publicado: (2022)

Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST)
por: Lattanzi, Simona, et al.
Publicado: (2021)

Effect of adjunctive perampanel on the quality of sleep and daytime somnolence in patients with epilepsy
por: González-Cuevas, Montserrat, et al.
Publicado: (2016)

Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)
por: Lattanzi, Simona, et al.
Publicado: (2021)

What’s behind drawing for an artist with left temporal lobe epilepsy? A multimodal neurophysiological study
por: Pauletto, Giada, et al.
Publicado: (2020)

Post-Stroke Status Epilepticus: Time of Occurrence May Be the Difference?
por: Nilo, Annacarmen, et al.
Publicado: (2023)

Cognitive effects of adjunctive perampanel for partial‐onset seizures: A randomized trial
por: Meador, Kimford J., et al.
Publicado: (2016)

Perampanel is also a useful adjunctive treatment option in refractory epilepsy in children
por: Kim, Jon Soo, et al.
Publicado: (2019)

Allopregnanolone and perampanel as adjuncts to midazolam for treating diisopropylfluorophosphate‐induced status epilepticus in rats
por: Dhir, Ashish, et al.
Publicado: (2020)

Risk Assessment by Pre-surgical Tractography in Left Hemisphere Low-Grade Gliomas
por: Ius, Tamara, et al.
Publicado: (2021)

Recurrent Status Epilepticus and SARS-CoV-2 infection: the “perfect storm”
por: Pauletto, Giada, et al.
Publicado: (2021)

Reply letter to “COVID-19 and Recurrent Status Epilepticus”
por: Pauletto, Giada, et al.
Publicado: (2022)

Meningioma-Related Epilepsy: A Happy Ending?
por: Pauletto, Giada, et al.
Publicado: (2023)

Efficacy and tolerability of adjunctive perampanel treatment in children under 12 years of age with refractory epilepsy
por: Yun, Yuni, et al.
Publicado: (2019)

New daily persistent headache after SARS-CoV- infection: A case series
por: Consoli, Stefano, et al.
Publicado: (2021)

Status migrainosus: a potential adverse reaction to Comirnaty (BNT162b2, BioNtech/Pfizer) COVID-19 vaccine—a case report
por: Consoli, Stefano, et al.
Publicado: (2021)

Perampanel and pregnancy
por: Vazquez, Blanca, et al.
Publicado: (2021)

Perampanel in Brain Tumor-Related Epilepsy: A Systematic Review
por: Tabaee Damavandi, Payam, et al.
Publicado: (2023)

Efficacy and Tolerability of Perampanel as Adjunctive Therapy in Chinese Patients With Focal-Onset Seizures: An Observational, Prospective Study
por: Zhang, Ranran, et al.
Publicado: (2021)

Cost-effectiveness of perampanel as an adjunctive treatment for uncontrolled focal seizures in pediatric patients: a Chinese perspective
por: Hu, Yani, et al.
Publicado: (2022)

Value of Perampanel as Adjunctive Treatment for Partial-Onset Seizures in Epilepsy: Cost-Effectiveness and Budget Impact Analysis
por: Zhang, Donger, et al.
Publicado: (2021)

Autonomic Status Epilepticus in a Patient with Parasellar Meningioma: A Case Report
por: Evangelista, Giacomo, et al.
Publicado: (2021)

Predictors of Pharmaco-Resistance in Patients with Post-Stroke Epilepsy
por: Lattanzi, Simona, et al.
Publicado: (2021)

Perampanel as first add-on antiseizure medication: Italian consensus clinical practice statements
por: Bonanni, Paolo, et al.
Publicado: (2021)

Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add‐on therapy compared to levetiracetam and valproic acid
por: Liguori, Claudio, et al.
Publicado: (2019)

The efficacy and safety of adjunctive perampanel for the treatment of refractory focal‐onset seizures in patients with epilepsy: A meta‐analysis
por: Li, Yiming, et al.
Publicado: (2022)

Effectiveness and tolerability of adjunctive perampanel in pediatric patients (aged 4–12 years) with refractory epilepsy: An observational study
por: Chu, Si-Jia, et al.
Publicado: (2022)

Correction: Perampanel as first add-on antiseizure medication: Italian consensus clinical practice statements
por: Bonanni, Paolo, et al.
Publicado: (2022)

Perampanel in lissencephaly-associated epilepsy
por: Ikemoto, Satoru, et al.
Publicado: (2019)

“Zombielike” Aggression in Perampanel Overdose
por: Morsi, Rami Z, et al.
Publicado: (2021)

Adjunctive Perampanel Oral Suspension in Pediatric Patients From ≥2 to <12 Years of Age With Epilepsy: Pharmacokinetics, Safety, Tolerability, and Efficacy
por: Renfroe, J. Ben, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b49ndl8qpofpd5qmkoo1rsu5mj